Michelle Chiam Sin Ling Discloses Investment at Aterian with 10% Stake

Aterian, Inc. (ATER) filed an SEC Form 8-K — Completion of Acquisition or Disposition of Assets. EX-10.1 3 ex_989840.htm EXHIBIT 10.1 ex_989840.htm Exhibit 10.1 CONTINGENT VALUE RIGHTS AGREEMENT by and between ATERIAN, INC., a Delaware corporation, and BROADRIDGE CORPORATE ISSUER SOLUTIONS, LLC , a Pennsylvania limited liability company, Dated as of July 17, 2026 i Table of

Aterian, Inc. (NASDAQ: ATER) adjourned its special stockholder meeting from July 10 to July 17, 2026. The vote concerns an asset sale of substantially all brand portfolios to Trademark Global, LLC and a related investment transaction. Aterian says the $18 million sale could return $0.85 to $1.14 per share, plus a $7 million investment.

SFL Corporation ordered two 93,000 cbm ammonia carriers for $216 million, deliverable in 2028. The company also secured long-term charters with an oil major, adding $162 million to its backlog. CEO Ole B. Hjertaker highlighted the investment's accretive nature and the charterer's investment-grade status. The total fixed-rate charter backlog for 2026 exceeds $1.3 billion.

Chevron (CVX) announced senior leadership changes effective January 1, 2027. Mark Nelson will focus on strategy and business development, Eimear Bonner will lead Oil, Products & Gas, Jeff Gustavson will become CFO, and Brent Gros will head New Energies and AI strategy. CEO Mike Wirth praised the new leaders' expertise and commitment.

Ultragenyx Pharmaceutical (NASDAQ: RARE) agreed to sell a rare pediatric disease priority review voucher for $210M, nearly half its cash reserves. The deal, subject to regulatory approval, follows the FDA's August approval of its Genglycos gene therapy. Shares rose 2.97% on the news. Ultragenyx plans to use proceeds to advance rare disease therapies and support profitability. The price is within the range of recent voucher transactions, such as Rocket Pharmaceuticals' $180M deal.

Warren Buffett and Berkshire Hathaway each report owning 12.5% of Lennar Corporation's Class A shares, totaling 26,034,436 shares with shared voting and dispositive power. National Indemnity Company holds 10.3%, or 21,502,349 shares. Other Berkshire affiliates also report significant stakes.